Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9535059rdf:typepubmed:Citationlld:pubmed
pubmed-article:9535059lifeskim:mentionsumls-concept:C0027763lld:lifeskim
pubmed-article:9535059lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9535059lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9535059lifeskim:mentionsumls-concept:C0521457lld:lifeskim
pubmed-article:9535059lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:9535059lifeskim:mentionsumls-concept:C0668289lld:lifeskim
pubmed-article:9535059lifeskim:mentionsumls-concept:C0678723lld:lifeskim
pubmed-article:9535059lifeskim:mentionsumls-concept:C1417063lld:lifeskim
pubmed-article:9535059lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:9535059lifeskim:mentionsumls-concept:C0458003lld:lifeskim
pubmed-article:9535059pubmed:issue2lld:pubmed
pubmed-article:9535059pubmed:dateCreated1998-5-8lld:pubmed
pubmed-article:9535059pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9535059pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9535059pubmed:abstractTextMelanocortins are thought to be involved in neuronal development and regeneration. Pro-opiomelanocortin (POMC), the precursor of alpha-melanocyte stimulating hormone (alpha-MSH), gamma-MSH, ACTH, and beta-endorphin, becomes detectable in rat hypothalamic neurons from gestational day (E) 12.5. We recently described stage- and region-specific ontogenetic patterns of binding sites for the alpha-MSH analogue [125I]-Nle4,D-Phe7-alpha-MSH ([125I]-NDP), with the first localizations in epithalamus and sympathetic chain at E13. [125I]-NDP binds to all known melanocortin receptors, including MC3-R and MC4-R, the predominant melanocortin receptors in nervous system. To identify the receptor type expressed during ontogeny, the developmental pattern of MC3-R and MC4-R mRNA was investigated by in situ hybridization in fetuses and offspring of time-pregnant Long Evans rats between E14 and postnatal day (P) 27. MC4-R mRNA was found to be the predominant species during the entire fetal period. It was localized in all fetal areas exhibiting distinct [125I]-NDP binding, starting with sympathetic ganglia and epithalamus (E14), and including sensory trigeminal nuclei (E16), dorsal motor nucleus of vagus (E16) and cranial nerve ganglia, inferior olive (E18) and cerebellum (E18), striatal regions (E16), and entorhinal cortex (E22). In contrast, MC3-R mRNA was detectable only in the postnatal period, with a fast increase in expression in the ventromedial and arcuate nuclei. The early presence of MC4-R mRNA in central and peripheral nervous system and transient regional peaks of mRNA expression, often concomitant with periods of neural network formation, suggest a role of this receptor type in early ontogeny. The MC3 receptor may be involved in analogous processes during postnatal development.lld:pubmed
pubmed-article:9535059pubmed:languageenglld:pubmed
pubmed-article:9535059pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9535059pubmed:citationSubsetIMlld:pubmed
pubmed-article:9535059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9535059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9535059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9535059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9535059pubmed:statusMEDLINElld:pubmed
pubmed-article:9535059pubmed:monthFeblld:pubmed
pubmed-article:9535059pubmed:issn0953-8194lld:pubmed
pubmed-article:9535059pubmed:authorpubmed-author:Lichtensteige...lld:pubmed
pubmed-article:9535059pubmed:authorpubmed-author:LauberM EMElld:pubmed
pubmed-article:9535059pubmed:authorpubmed-author:Kistler-HeerV...lld:pubmed
pubmed-article:9535059pubmed:issnTypePrintlld:pubmed
pubmed-article:9535059pubmed:volume10lld:pubmed
pubmed-article:9535059pubmed:ownerNLMlld:pubmed
pubmed-article:9535059pubmed:authorsCompleteYlld:pubmed
pubmed-article:9535059pubmed:pagination133-46lld:pubmed
pubmed-article:9535059pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9535059pubmed:meshHeadingpubmed-meshheading:9535059-...lld:pubmed
pubmed-article:9535059pubmed:meshHeadingpubmed-meshheading:9535059-...lld:pubmed
pubmed-article:9535059pubmed:meshHeadingpubmed-meshheading:9535059-...lld:pubmed
pubmed-article:9535059pubmed:meshHeadingpubmed-meshheading:9535059-...lld:pubmed
pubmed-article:9535059pubmed:meshHeadingpubmed-meshheading:9535059-...lld:pubmed
pubmed-article:9535059pubmed:meshHeadingpubmed-meshheading:9535059-...lld:pubmed
pubmed-article:9535059pubmed:meshHeadingpubmed-meshheading:9535059-...lld:pubmed
pubmed-article:9535059pubmed:meshHeadingpubmed-meshheading:9535059-...lld:pubmed
pubmed-article:9535059pubmed:meshHeadingpubmed-meshheading:9535059-...lld:pubmed
pubmed-article:9535059pubmed:meshHeadingpubmed-meshheading:9535059-...lld:pubmed
pubmed-article:9535059pubmed:meshHeadingpubmed-meshheading:9535059-...lld:pubmed
pubmed-article:9535059pubmed:meshHeadingpubmed-meshheading:9535059-...lld:pubmed
pubmed-article:9535059pubmed:year1998lld:pubmed
pubmed-article:9535059pubmed:articleTitleDifferent developmental patterns of melanocortin MC3 and MC4 receptor mRNA: predominance of Mc4 in fetal rat nervous system.lld:pubmed
pubmed-article:9535059pubmed:affiliationInstitute of Pharmacology, University of Zürich, Switzerland.lld:pubmed
pubmed-article:9535059pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9535059pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9535059lld:pubmed